| Financial Ratios | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Return on Equity | -8.3 | -7.74 | -1.035 | -4.343 |
| Net Profit Margin | -6,459.946 | -6,093.766 | -51.045 | -168.956 |
| Debt to Asset Ratio | 8.538 | 10.322 | 5.278 | 6.661 |
| Cash Ratio | 2,190.127 | 1,407.931 | 2,878.433 | 1,988.691 |
| Quick Ratio | 2,261.55 | 1,545.185 | 2,985.667 | 2,111.413 |
| Current Ratio | 2,261.55 | 1,545.185 | 2,985.667 | 2,111.413 |
Keros Therapeutics, Inc. (KROS)
Keros Therapeutics, Inc. (KROS)